The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Bladder Cancer. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Denmark
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life - What is the Cost of the Cure?
Overview
Bladder Cancer prognosis, treatment, and subsequent morbidity and mortality vary between the different stages, thus resulting in a different impact on patients' lives. There are some well known late effects of the treatments for bladder cancer, but the knowledge of their impact on patients Quality of Life is sparse. This study aims to determine the prevalence of late effects impact on Quality of Life and potential risk factors for impairment.
Primary outcome measures
- Health-related Quality of Life [Time frame: 5 years from baseline inclusion]
Secondary outcome measures (1)
- Prevalence of late effects [Time frame: 5 years from baseline inclusion]
Eligibility criteria
Inclusion criteria
- Patients are eligible if they are referred to a hospital in the Central Region Denmark, due to hematuria between 01/01/2022 and 01/01/2023
- Ability to understand written and oral Danish
Exclusion criteria
- Known Alzheimers disease
- Diagnosed other causes explaining the hematuria
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Denmark · 5 centers
- Department of Urology, Aarhus University Hospital — Aarhus N
- Department of Urology, Regional Hospital Gødstrup — Gødstrup
- Department of Urology, Regional Hospital Horsens — Horsens
- Department of Urology, Regional Hospital Randers — Randers
- Department of Urology, Regional Hospital Viborg — Viborg
Identifiers
NCT: NCT05195515 · CONQUER